Cellares will collaborate with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative Medicines Accelerator (IMA) to automate manufacturing and release testing for ...
AZoLifeSciences on MSN
Cellares to expand automated manufacturing to gene-edited stem cell therapies
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results